Комментарии:
I disagree with mandating cost free preventive care, all it does it shifts the cost into premia and deductible. There should be a nominal cost share for things like vaccines etc.
ОтветитьAlso, doesn’t the affordable insulin now act cap prices not only for Medicare part d but also private insurance plans?
ОтветитьYes the cost will be past on.
ОтветитьDr. Bricker, you have no idea how your videos are impacting folks - a TREMENDOUS VALUE ADD to both the health care delivery AND health insurance industries. And I agree 100% this is the beginning of universal healthcare. Boom.
ОтветитьHi Doctor! Have you made any videos on drug pricing and the pros and cons for price controls in this area?
ОтветитьWhen we talk about provisions that apply to "Part D" (I'm interested in the $35 insulin copay cap in particular), should we consider this to include Medicare standalone PDP plans AND Medicare Advantage plans that include Part D coverage (MAPD)? I'm thinking about the implications this will have on how health plans will rank on Medicare's plan finder and if MAO's will have time to account for this in formularies posted ahead of the 2023 Annual Election Period. Thanks for your videos btw, I share them with my health plan colleagues often!
ОтветитьWith Medicare expansion by lowering age eligibility, doesn’t that go against how the Medicare Part A HI trust fund is expected to deplete by 2026-2030? One of the strategies to help the HI fund is by increasing eligibility age, not decreasing. I’m assuming there is an offset somewhere on increasing member cost sharing , payroll taxes, etc
ОтветитьDr. Bricker, on negotiating drug prices could you please clarify a point for me? I believe that Medicare Part A covers drugs that you receive while in the hospital; Medicare Part B covers a few outpatient prescription drugs; and Medicare Part D is the prescription drug plan that someone on Medicare can purchase from an insurance company. So when everyone says that Medicare isn't permitted to negotiate drug prices with pharma companies it only relates to the limited circumstances of the drugs covered under Parts A & B, not Part D as the insurance companies sponsoring the Part D plans are already negotiating with the pharma companies. Is that correct?
ОтветитьInteresting thank you
Ответить